In addition, our study showed that serum asprosin levels in obesity were higher than normal in controls and consistent with previous studies on serum asprosin levels in obese patients [6, 9, 27], and serum asprosin levels were positively correlated with BMI in controls and total subjects in our study. This evidence concerns the gene FBN1 and obesity disorder.